Rheumatoid arthritis (RA) is a chronic inflammatory disorder that significantly impacts more than just the joints. It can also affect various body systems, including the skin, eyes, lungs, heart, and blood vessels. This comprehensive exploration delves into the intricate relationship between RA and hypertension, highlighting the critical associations and implications for those affected.
A notable aspect of RA is its connection with inflammation and blood pressure (BP). Studies, including those focusing on RA and non-RA outpatients, have revealed a broad spectrum of inflammation’s impact on BP. People with rheumatoid arthritis are at an increased risk of high blood pressure, also known as hypertension. Research indicates that hypertension prevalence in individuals with RA ranges from 52 percent to 73 percent, signifying a significant comorbidity.
Recent findings from Australian researchers underscore the potential risks associated with fluctuating blood pressure. These variations in BP can elevate the risk of dementia and vascular problems, particularly in older populations. The intersection of rheumatoid arthritis, hypertension, and other health issues like metabolic syndrome (found in nearly 40% of RA patients) underscores the systemic nature of RA.
Treatment options for patients with both hypertension and arthritis pain are evolving. Naproxcinod, a promising therapeutic agent, offers potential benefits by mitigating the negative effects on blood pressure and gastrointestinal issues commonly associated with traditional arthritis therapies.
For further insights into rheumatoid arthritis and its systemic effects, explore these resources:
Mayo Clinic
Inflammation and Blood Pressure in RA
High Blood Pressure and RA
Fluctuating Blood Pressure Study
RA’s Whole Body Impact
RA and Heart Disease
Hypertension and Arthritis Pain Treatment
